HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta.

Abstract
Human endothelial cells produced a neutrophil chemotactic factor (NCF) upon stimulation with tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), or lipopolysaccharide (LPS). The expression of endothelial cell-derived NCF messenger RNA and biological activity was both time- and concentration-dependent. Maximal NCF mRNA expression occurred at 10 and at 2 nanograms per milliliter for TNF and IL-1 beta, respectively; mRNA expression was first observed 1 hour after stimulation and was maintained for at least 24 hours. In situ hybridization analysis showed that NCF mRNA peaked in treated cells by 24 hours, whereas unstimulated cells were negative. These studies demonstrated that endothelial cells may participate in neutrophil-mediated inflammation by synthesizing a chemotactic factor in response to specific monokines and LPS.
AuthorsR M Strieter, S L Kunkel, H J Showell, D G Remick, S H Phan, P A Ward, R M Marks
JournalScience (New York, N.Y.) (Science) Vol. 243 Issue 4897 Pg. 1467-9 (Mar 17 1989) ISSN: 0036-8075 [Print] United States
PMID2648570 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Chemotactic Factors
  • Interleukin-1
  • Interleukin-8
  • Lipopolysaccharides
  • Oligonucleotide Probes
  • Tumor Necrosis Factor-alpha
Topics
  • Blotting, Northern
  • Chemotactic Factors (genetics)
  • Endothelium, Vascular (physiology)
  • Gene Expression Regulation (drug effects)
  • Humans
  • In Vitro Techniques
  • Interleukin-1 (pharmacology)
  • Interleukin-8
  • Lipopolysaccharides (pharmacology)
  • Oligonucleotide Probes
  • Time Factors
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: